Company insider dossier

Novavax Inc insider intelligence

NVAX filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.

Terminal chart Weekly report Factor intelligence Healthcare Biotechnology Data API
50/100

No directional read

35/100 confidence
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Latest evidence
20 Jun 2026

Investment committee read

No directional read

The tape contains filings, but none provide enough priced common-share evidence for a directional classification.

Evidence is contextual

Evidence in favour

  • Participation spans 9 named insiders rather than one filing source.

Decision risks

  • Most filings are awards, derivatives, unpriced common shares, or other securities and remain contextual.
Conviction50No directional read
Confidence35Thin evidence
Named insiders9participating in the tape
Controlled events0directional common-share events
Acquisition value$0normalized amount
Disposal value$0normalized amount

Price confirmation map

Weekly price with common-share events

Acquisitions and disposals are aligned to the nearest completed weekly bar.

10.979.698.427.145.86 Acquisition · 20 Jun 2026 · Not reportedAcquisition · 20 Jun 2026 · Not reportedAcquisition · 20 Jun 2026 · Not reportedAcquisition · 20 Jun 2026 · Not reportedAcquisition · 20 Jun 2026 · Not reportedAcquisition · 20 Jun 2026 · Not reportedAcquisition · 25 Apr 2026 · Not reported
Mar 2025Sep 2026
Weekly closeCommon-share acquisitionCommon-share disposal

Market confirmation

Price and trend context

Latest close
10.11 USD
One-week move
+7.3%
Four-week move
+13.1%
Fair-value gap
+21.1%
Trend signal
Inactive
Relative strength
6.6

Directional balance

Controlled event mix

0%acquisition
Acquisition events
0
Disposal events
0
Net value
$0

Cadence

Twelve-week filing pressure

Volume shows attention. Controlled events determine direction.

006 Jul
013 Jul
020 Jul
027 Jul
003 Aug
010 Aug
017 Aug
024 Aug
031 Aug
007 Sep
014 Sep
021 Sep

Named participants

Insider conviction by person

NEWTON, CHARLES W.Director500 events
ALTON, GREGG HDirector500 events
DOUGLAS, RICHARDDirector500 events
KING, RACHEL K.Director500 events
MCGLYNN, MARGARET GDirector500 events
MOTT, DAVID MDirector500 events
RODGERS, RICHARD JDirector500 events
SHIVER, JOHN W.Director500 events
WALKER, ROBERT EDWARDEVP, R&D500 events

Evidence quality

Security and transaction context

Common equity7
Equity compensation16
Options and derivatives9
Other securities0

Role architecture

Who is participating

Director30
Other or unspecified2

Transaction evidence

Auditable NVAX filing ledger

Showing 1 to 30 of 32.

ALTON, GREGG HDirector
DisposalEquity compensation
18880 sharesRestricted Stock Units
Not reportedContext evidence
ALTON, GREGG HDirector
AcquisitionCommon equity
18880 sharesCommon Stock
Not reportedContext evidence
DOUGLAS, RICHARDDirector
DisposalEquity compensation
18880 sharesRestricted Stock Units
Not reportedContext evidence
DOUGLAS, RICHARDDirector
AcquisitionCommon equity
18880 sharesCommon Stock
Not reportedContext evidence
KING, RACHEL K.Director
AcquisitionCommon equity
18880 sharesCommon Stock
Not reportedContext evidence
KING, RACHEL K.Director
DisposalEquity compensation
18880 sharesRestricted Stock Units
Not reportedContext evidence
MCGLYNN, MARGARET GDirector
AcquisitionCommon equity
18880 sharesCommon Stock
Not reportedContext evidence
MCGLYNN, MARGARET GDirector
DisposalEquity compensation
18880 sharesRestricted Stock Units
Not reportedContext evidence
MOTT, DAVID MDirector
AcquisitionCommon equity
18880 sharesCommon Stock
Not reportedContext evidence
MOTT, DAVID MDirector
DisposalEquity compensation
18880 sharesRestricted Stock Units
Not reportedContext evidence
RODGERS, RICHARD JDirector
AcquisitionCommon equity
18880 sharesCommon Stock
Not reportedContext evidence
RODGERS, RICHARD JDirector
DisposalEquity compensation
18880 sharesRestricted Stock Units
Not reportedContext evidence
ALTON, GREGG HDirector
AcquisitionEquity compensation
14180 sharesRestricted Stock Units
Not reportedContext evidence
ALTON, GREGG HDirector
AcquisitionOptions and derivatives
21270 sharesStock Option (Right to Buy)
Not reportedContext evidence
DOUGLAS, RICHARDDirector
AcquisitionOptions and derivatives
21270 sharesStock Option (Right to Buy)
Not reportedContext evidence
DOUGLAS, RICHARDDirector
AcquisitionEquity compensation
14180 sharesRestricted Stock Units
Not reportedContext evidence
KING, RACHEL K.Director
AcquisitionOptions and derivatives
21270 sharesStock Option (Right to Buy)
Not reportedContext evidence
KING, RACHEL K.Director
AcquisitionEquity compensation
14180 sharesRestricted Stock Units
Not reportedContext evidence
MCGLYNN, MARGARET GDirector
AcquisitionOptions and derivatives
21270 sharesStock Option (Right to Buy)
Not reportedContext evidence
MCGLYNN, MARGARET GDirector
AcquisitionEquity compensation
14180 sharesRestricted Stock Units
Not reportedContext evidence
MOTT, DAVID MDirector
AcquisitionEquity compensation
14180 sharesRestricted Stock Units
Not reportedContext evidence
MOTT, DAVID MDirector
AcquisitionOptions and derivatives
21270 sharesStock Option (Right to Buy)
Not reportedContext evidence
NEWTON, CHARLES W.Director
AcquisitionEquity compensation
14180 sharesRestricted Stock Units
Not reportedContext evidence
NEWTON, CHARLES W.Director
AcquisitionOptions and derivatives
21270 sharesStock Option (Right to Buy)
Not reportedContext evidence
RODGERS, RICHARD JDirector
AcquisitionOptions and derivatives
21270 sharesStock Option (Right to Buy)
Not reportedContext evidence
RODGERS, RICHARD JDirector
AcquisitionEquity compensation
14180 sharesRestricted Stock Units
Not reportedContext evidence
SHIVER, JOHN W.Director
AcquisitionOptions and derivatives
21270 sharesStock Option (Right to Buy)
Not reportedContext evidence
SHIVER, JOHN W.Director
AcquisitionEquity compensation
14180 sharesRestricted Stock Units
Not reportedContext evidence
NEWTON, CHARLES W.Director
AcquisitionCommon equity
9520 sharesCommon Stock
Not reportedContext evidence
NEWTON, CHARLES W.Director
DisposalEquity compensation
9520 sharesRestricted Stock Units
Not reportedContext evidence

Reading the dossier

Direction and confidence are separate

Conviction

The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.

Confidence

Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.

Disposals

Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.

Price confirmation

The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context